The prevalence of obesity is increasing and progressively influencing physician﹑atient interactions. While there is a sizable amount of data demonstrating that obesity is a state of lowゞrade inflammation, to our knowledge, there is no single review summarizing its effects on hematologic parameters ...
The hematologic consequences of obesity. Eur. J. Haematol. 2021, 106, 306–319. [Google Scholar] [CrossRef] [PubMed] Agrawal, M.; Kern, P.A.; Nikolajczyk, B.S. The immune system in obesity: Developing paradigms amidst inconvenient truths. Curr. Diabetes Rep. 2017, 17, 87. [Google...
Cytokine storms characterize a wide spectrum of infectious and non-infectious diseases, and since 2005, it was associated to the avian H5N1 influenza virus infection [9]. Apart from the immediate significance of the term cytokine storm, the biological and clinical consequences of this immune system...
select article The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) Short communicationFull text access The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic ...
The impact of obesity on stem cell transplant. In: Mittelman SD, Berger NA (ed.) Energy Balance and Hematologic Malignancies. Springer: New York, 2012, pp 129–140. Google Scholar Wyatt SB, Winters KP, Dubbert PM . Overweight and obesity: prevalence, consequences, and causes of a growing...
Risk factors for VTE included diagnosed thrombophilia (defined as ICD codes for “primary hypercoagulable state” and “secondary hypercoagulable state”), hypercoagulable hematologic conditions, and cancer. We were not able to distinguish between active and inactive cancer. Kidney function was ...
The idea that vaccines could have negative consequences was articulated early in the pandemic. In March of 2020, in the journalNature, Shibo Jiang, a vaccine researcher wrote an article entitled, “Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees” (Jiang202...
Congenital disorder of glycosylation III (CDG2L) is also autosomal recessive, characterized by intrauterine growth retardation, gastrointestinal abnormalities, infection and hematologic abnormalities. CDG2L usually results in death in infancy72. In case 94162, a homozygous mutation with uncertain clinical ...
Adverse drug reactions can be caused by the parent drug or a metabolite of that drug. The metabolite may be stable or chemically reactive, the resultant to
(fully excised with no recurrence); the presence of an unstable cardiovascular, endocrinologic, hematologic, hepatic, renal, or neurologic disease (determined by physical examination and laboratory testing); a history of schizophrenia (determined by use of the Structured Clinical Interview forDSM-IV)...